USA Financial Formulas’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-10,067
Closed -$865K 401
2018
Q2
$865K Sell
10,067
-43
-0.4% -$4.7K 0.21% 89
2018
Q1
$868K Buy
+10,110
New +$783K 0.21% 89
2017
Q3
Sell
-10,787
Closed -$691K 336
2017
Q2
$691K Buy
+10,787
New +$665K 0.17% 125
2017
Q1
Sell
-17,969
Closed -$1.1M 344
2016
Q4
$1.1M Buy
17,969
+2,401
+15% +$156K 0.27% 81
2016
Q3
$1.08M Sell
15,568
-5,130
-25% -$338K 0.28% 84
2016
Q2
$1.15M Buy
+20,698
New +$1.25M 0.32% 82
2015
Q3
Sell
-33,936
Closed -$2.32M 203
2015
Q2
$2.32M Sell
33,936
-10,148
-23% -$644K 0.71% 37
2015
Q1
$2.45M Buy
44,084
+3,908
+10% +$200K 0.8% 38
2014
Q4
$2.06M Buy
+40,176
New +$1.97M 0.71% 52

Other funds holding USNA

USA Financial Formulas's USNA Position: Q3 2018 in Review

USA Financial Formulas sold out of Usana Health Sciences (USNA) in Q3 2018, closing a stake of 10,067 shares — an estimated $865K sold.

USA Financial Formulas first reported a position in USNA in Q4 2014 and held it in 9 quarters. The position peaked at $2.45M in Q1 2015. 197 funds tracked by Wall St. Rank hold USNA as of Q3 2018.

  • USA Financial Formulas reported no remaining Usana Health Sciences position as of Q3 2018 after selling out during the quarter.
  • USA Financial Formulas sold 10,067 Usana Health Sciences shares in Q3 2018, an estimated $865K.
  • USA Financial Formulas first reported a position in Usana Health Sciences in Q4 2014 and held it in 9 quarters.
  • USA Financial Formulas's Usana Health Sciences position peaked at $2.45M in Q1 2015.
  • 197 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2018.

Based on USA Financial Formulas's 13F filing for Q3 2018, filed 31 Oct 2018.